Explore All Access
Check if your research matches the topics covered in Journal of Chemotherapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Journal of Chemotherapy : Impact Factor & More
eISSN: 1973-9478pISSN: 1120-009X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Journal of Chemotherapy Key Metrics
CiteScore 
3.1
H-Index
55
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.63
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months15%
4 to 6 months56%
7 to 9 months20%
Above 9 months10%
Did you find this useful?
Topics Covered on Journal of Chemotherapy
Cancer
Infective endocarditis
Colistin
Staphylococcus aureus
Antimicrobial stewardship
Escherichia coli
Case series
Vancomycin
Klebsiella pneumoniae
Second-line therapy
Voriconazole
Regorafenib
Pseudomonas aeruginosa
Overall survival
Systematic review
Adult patients
Bacteremia
Paclitaxel
Antibiotic prescribing
Genotype
Journal of Chemotherapy Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of Chemotherapy
Evaluating omadacycline dosing regimens against drug-resistant pathogens including Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
- 1 Nov 2024
- Journal of chemotherapy (Florence, Italy)
Transcriptional factor KLF9 overcomes 5-fluorouracil resistance in breast cancer via PTEN-dependent regulation of aerobic glycolysis
- 26 Oct 2024
- Journal of Chemotherapy
Mpox outbreak in a cluster of hospitals at Riyadh, Saudi Arabia 2022-2023: clinical presentation, risk factors, and preventive measures.
- 24 Oct 2024
- Journal of chemotherapy (Florence, Italy)
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells
- 24 Oct 2024
- Journal of Chemotherapy
Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital.
- 21 Oct 2024
- Journal of chemotherapy (Florence, Italy)
Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy.
- 15 Oct 2024
- Journal of chemotherapy (Florence, Italy)
Evaluating omadacycline dosing regimens against drug-resistant pathogens including Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
- 1 Nov 2024
- Journal of chemotherapy (Florence, Italy)
Transcriptional factor KLF9 overcomes 5-fluorouracil resistance in breast cancer via PTEN-dependent regulation of aerobic glycolysis
- 26 Oct 2024
- Journal of Chemotherapy
Mpox outbreak in a cluster of hospitals at Riyadh, Saudi Arabia 2022-2023: clinical presentation, risk factors, and preventive measures.
- 24 Oct 2024
- Journal of chemotherapy (Florence, Italy)
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells
- 24 Oct 2024
- Journal of Chemotherapy
Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital.
- 21 Oct 2024
- Journal of chemotherapy (Florence, Italy)
Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy.
- 15 Oct 2024
- Journal of chemotherapy (Florence, Italy)
Compare Similar Journals with Journal of Chemotherapy
Select Journals to Compare with Journal of Chemotherapy
Total journals - 10
You can select up to 3 Journals at a time
Open Forum Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Journal of Global Antimicrobial Resistance
Publisher: ELSEVIER SCI LTD
Antibiotics
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Infectious Diseases
Publisher: ELSEVIER SCI LTD
Scientific Reports
Publisher: NATURE PORTFOLIO
BMC Infectious Diseases
Publisher: BMC
Infection and Drug Resistance
Publisher: DOVE MEDICAL PRESS LTD
Medicine
Publisher: Elsevier
Clinical Microbiology and Infection
Publisher: ELSEVIER SCI LTD
0 Journals Selected to compare with
Journal of Chemotherapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Journal of Chemotherapy
How long has Journal of Chemotherapy been actively publishing? 
Journal of Chemotherapy has been in operation since 1989 till date.
What is the publishing frequency of Journal of Chemotherapy?
Journal of Chemotherapy published with a Bi-monthly frequency.
How many articles did Journal of Chemotherapy publish last year?
In 2023, Journal of Chemotherapy publsihed 74 articles.
What is the eISSN & pISSN for Journal of Chemotherapy?
For Journal of Chemotherapy, eISSN is 1973-9478 and pISSN is 1120-009X.
What is Citescore for Journal of Chemotherapy?
Citescore for Journal of Chemotherapy is 3.1.
What is the H Index for Journal of Chemotherapy ?
H Index for Journal of Chemotherapy is 55.
What is SNIP score for Journal of Chemotherapy?
SNIP score for Journal of Chemotherapy is 0.63.
What is the SJR for Journal of Chemotherapy?
SJR for Journal of Chemotherapy is Q3.
Who is the publisher of Journal of Chemotherapy?
TAYLOR & FRANCIS LTD is the publisher of Journal of Chemotherapy.
